Search
logo
Search
The article is in preview mode

Hepatitis Causes, symptoms, diagnosis and treatment

Homepage Articles Hepatitis Causes, symptoms, diagnosis and treatment

Hepatitis Causes, symptoms, diagnosis and treatment

Stabilizing the progression of the disease depends on the proper prevention of the complications of obesity and the early introduction of therapeutic intervention. Liver obesity is a disease that is associated with a high risk of mortality, until recently it was thought that only a transplant gives a chance of survival. In some cases, the delay (even in obesity) can be reversed with the use of targeted therapy.

Table of Contents

1. What's a fatty liver?

The effects of this are impaired liver metabolic function, reduced bile flow, and the development of hypertension, which lead to many complications. These changes lead to a reduction in active spleen and prevent normal spleen circulation. Liver cirrhosis is a chronic disease resulting from spleen fibrillation and the transformation of the normal structure of the liver into regenerative tumour disease.

2. Liver failure is the cause

Ethiological factors can be divided into: toxic viral damage to the liver occurs as a result of contact with alcohol (alcoholic fatty liver disease occurs in 80% of cases of fatty heart disease), medicines (such as methotrexate, amiodarone, methylodopa), chemicals (like carbon tetrahydrocannabinol, dimethyl nitrosamine), toxic fungi; virus liver damage occurs due to exposure to the hepatitis C virus (alcohol-related liver disease affects 80% of the cases of liver disease), and chemotherapeutic agents (like amyodaron, methylodopa), which lead to inflammation of the hepatitis B virus (which is the most important cause of inflammatory bowel disease in the gastrointestinal tract), which is the main cause of liver failure in the digestive tract and in the intestinal tract; it is associated with diseases such as autoimmune diseases, such as Alzheimer's disease, hyperthyroidism in the liver, and metabolic disorders such as carcinoma in the spinal tract (e.g.

3. Hepatitis A is a medical condition characterized by inflammation of the liver

Symptoms reported by the patient can be divided into: symptoms of the digestive system swelling, nausea and vomiting, fatigue and/ or fatigue, reduced fitness, fever, lack of appetite, feeling full in the abdomen, weight loss, painful muscle contractions, swelling of the lower extremities, bleeding from the joints and nose; signs of the gastrointestinal tract inflammation, nausiness and fatigue of the genitals, constipation and/or fatigue in the body, insufficient fat and alcohol intake, abdominal pain in the right abdomen;  symptoms of deeply inflamed skin, muscle spasms in the back of the legs, inflammation in the lower limbs, bloating of the ribs, bleaching of the fingers and toes, bleach of the nose and nose, and bleaching of the mouth and nose. Signs and symptoms: symptoms of asthma, asthma and asthma in men and women: symptoms, symptoms, signs, symptoms and symptoms in men, symptoms of severe asthma; symptoms of heartburn in men; symptoms, ast

4. Liver failure is complicated

The causes of liver cirrhosis are related to: organ dysfunction such as jaundice, coagulation disorders, hypoalbuminemia, protein-energetic malnutrition; hepatic hypertension, which leads to the appearance of obstructive pulmonary circulation in the bladder, esophagus or abdominal lining; insulin resistance, which develops in 60% of patients and in 20% leads to development of diabetes mellitus; hydrocephalus; liver encephalopathy, the end stage of which is liver disease.

5. Hepatitis C is the diagnosis

In liver morphology studies, hepatic impairment may be measured in small amounts, macroblasty and leukopenia. In order to diagnose liver morphogenesis, it is sufficient to identify disorders in the production of albumin or prothrombin and irregular, vascular liver tissue in an ultrasound, computed tomography, or magnetic resonance imaging. Additional information on the frequency may be provided by measuring the hepatic-angiotomy gradient (HVPG) to assess the blood pressure in the liver gland.

6. Hepatitis A is a stage

The Childa-Pugha triangular scale defines class A as an uneven liver marrow with no indications for transplantation, and classes B and C as a non-uniform liver marrows with indications of organ transplantation (Table 1). The Childe-Pugah *PBC classification of liver failure primary biliary cholangitis (PBC) Own development based on: Cholongitas E. Et al., Systematic review: The model for end-stage liver disease--should it replace-Pugh's classification for assessing prognosis inrhosis?, Alimentary Pharmacotherapy & Child Therapeutics 22,799.

7. Hepatitis Treatment and diet

In order to prevent encephalopathy, it is recommended to limit the intake of aromatic amino acids (phenyloalanine, tryptophan, tyrosine) to branched-chain amino acid (BCAAs) such as walin, leucine and isocetamine. The amount of energy supplied should be 20% greater than the basic metabolic rate. In general, it's recommended to reduce the amount of amino acid (phenolalanine, triptophane, tyrozines) consumed from all the carbohydrates in the body. It' s recommended to increase the body' s metabolism and metabolism of calcium and calcium oxides from the body to the body, so that it' s possible to include calcium carbonate in the blood, calcium, magnesium and magnesium oxides in the liver, and in case of blood, it should be possible to eliminate the two main ingredients, namely calcium chloride (calcium oxide) and vitamin C, which can be used to reduce blood pressure in patients with diabetes mellitus.

8. Liver frequency is estimated

Study shows that survival is closely linked to improved liver morbidity (Table 3). Survival of people with liver failure on the Childa-Pugha scale However, they need to be monitored and controlled accordingly. Since the onset of the first stage of liver disease Cholongitas E. et al., Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?, Alimentary Pharmacology & Therapeutics 2005, 22,10791089.

Category:
Source

Ołdakowska-Jedynak U., Choroby wątroby, Choroby wewnętrzne – podręcznik dla studentów pielęgniarstwa i położnictwa, pod red. Pączka L., Muchy K., Foroncewicza B., Warszawa 2009, 312–314.
Błaut-Kądzielska U., Dobrek Ł., Choroby układu pokarmowego, Podstawy patofizjologii człowieka, pod red. Thora P., Kraków 2009, 233–243.
Tsochatzis E.A., Bosch J., Burroughs A.K., Liver cirrhosis, „Lancet” 2014, 383, 1749–1761.
Szymczak A. et al., Wpływ alkoholu na wybrane schorzenia przewodu pokarmowego, „Nowiny Lekarskie” 2009, 78(3–4), 222–227.
Guidance for Industry Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling, fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM072123.pdf (12.02.2018).
Romano M.M., Aranda-Michel J., Żywienie w chorobach wątroby, Dietetyka i żywienie kliniczne, pod red. Chojnackiego J., Wrocław 2013, 147–157.
Barkoukis H., Fiedler K.M., Lerner E., A combined high-fiber, low-glycemic index diet normalizes glucose tolerance and reduces hyperglycemia and hyperinsulinemia in adults with hepatic cirrhosis, „Journal of the American Dietetic Association” 2002, 102(10), 1503–1507.
Jenkins D.J. et al., Low glycemic index foods and reduced glucose, amino acid, and endocrine responses in cirrhosis, „American Journal of Gastroenterology” 1989, 84(7), 732–739.
Dziewiatowska J. et al., Przyczyny niedożywienia, ocena stanu odżywienia i zalecenia żywieniowe w marskości wątroby, „Forum Zaburzeń Metabolicznych” 2016, 7(1), 16–23.
World Health Organization, Global Health Observatory: Top 10 causes of death 2015, who.int/gho (07.01.2018).
D’Amico G., Garcia-Tsao G., Pagliaro L., Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies, „Journal of Hepatology” 2006, 44, 217–231.